Larvol Delta - Calidi-Biotherapeutics-Presents-New-Data-on-Its-Differentiated-Approach-to-In-Situ-TCell-Engagers-Including-a-New-Candidate-Targeting-TROP2-at-the-AACR-Annual-Meeting-in-April-2026

CLD-501 - Calidi Biotherap

CLD-401 - Calidi Biotherap

https://www.globenewswire.com/news-release/2026/04/20/3276929/0/en/Calidi-Biotherapeutics-Presents-New-Data-on-Its-Differentiated-Approach-to-In-Situ-T-Cell-Engagers-Including-a-New-Candidate-Targeting-TROP-2-at-the-AACR-Annual-Meeting-in-April-20.html

Apr 20, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next